PLx Pharma Inc reports results for the quarter ended in June - Earnings Summary

PLx Pharma Winddown

12/08/2022 14:31

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted
loss
of 43 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 56 cents per share.
    * Revenue was $483.00 million​; analysts expected $3.53
million. 
    * PLx Pharma Inc's reported EPS for the quarter was a loss
of 43
cents​.
    * The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * PLx Pharma Inc shares had risen by 6.6% this quarter and
lost 67.7% so far this year.
    * The company reported a quarterly loss of $11.86 million.
    * Wall Street's median 12-month price target for PLx Pharma
Inc is
$11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 12
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.56          -0.43          Beat
 Mar. 31 2022      -0.72          -0.39          Beat
 Dec. 31 2021      -0.71          0.10           Beat
 Sep. 30 2021      -0.46          -0.80          Missed